Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 43 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

26%

11 trials in Phase 3/4

Results Transparency

38%

5 of 13 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

32Total
Not Applicable (16)
P 1 (3)
P 2 (2)
P 3 (5)
P 4 (6)

Trial Status

Unknown17
Completed13
Active Not Recruiting5
Recruiting5
Not Yet Recruiting2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT07176104Not ApplicableNot Yet Recruiting

Functional Milk Supplementation to Reduce In-Stent Restenosis in STEMI Patients (SMASOEA Trial)

NCT04647253Phase 3Active Not RecruitingPrimary

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)

NCT06492174Phase 3Active Not RecruitingPrimary

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort

NCT07533656Active Not RecruitingPrimary

VAP-Measured Lipid Subfractions and In-Stent Restenosis After PCI

NCT05509296Not ApplicableCompleted

Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease

NCT07382154Not Yet RecruitingPrimary

Target Vessel Failure After Laser Assisted Percutaneous Angioplasty Versus Balloon-based Treatment for Drug Eluting In-stent Restenosis

NCT07297641Recruiting

Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR

NCT05731700Not ApplicableCompletedPrimary

CVT-ISR First in Human Trial for Coronary In-Stent Restenosis

NCT06117150Phase 1Active Not RecruitingPrimary

Pilot Study of the Coronary Spur Stent for In-stent Restenosis (DEEPER CORONARY)

NCT06090890Phase 4RecruitingPrimary

Anti-inflammatory Therapy for Recurrent In-stent Restenosis

NCT05656118Active Not RecruitingPrimary

Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR)

NCT06968858Phase 1RecruitingPrimary

Pilot Study of the α Prototype NIMBLE System: Feasibility, Safety, and Initial Performance in Non-Invasive Detection of Coronary In-Stent Restenosis

NCT05908331Not ApplicableRecruitingPrimary

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

NCT04985773Not ApplicableCompleted

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon

NCT06148441UnknownPrimary

Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention

NCT05623995Phase 4UnknownPrimary

Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)

NCT06104007Recruiting

Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study

NCT04268875Not ApplicableCompletedPrimary

Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT

NCT05093244Not ApplicableWithdrawn

Resveratrol Excipient Paclitaxel Coated Balloon for Coronary Treatment

NCT05611190Not ApplicableUnknown

CT-FFR-guided Strategy for In-stent Restenosis

Scroll to load more

Research Network

Activity Timeline